Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Genetics |
RCV001171596 | SCV001334392 | pathogenic | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001171596 | SCV002239416 | pathogenic | not provided | 2024-03-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg691*) in the CACNA1F gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CACNA1F are known to be pathogenic (PMID: 9662399, 11281458, 17525176, 22194652, 24124559, 26992781). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with congenital stationary night blindness (PMID: 15761389, 23714322). This variant is also known as c.2038C>T (R680X). ClinVar contains an entry for this variant (Variation ID: 916094). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252322 | SCV002523333 | likely pathogenic | See cases | 2019-10-29 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1, PM2 |